FDA grants Breakthrough Therapy status to luvesilocin (RE104), a single-dose psychedelic treatment for postpartum depression offering remission in days.
The new 2026 U.S. Dietary Guidelines have arrived, introducing an 'inverted' food pyramid and doubling protein targets to 1.6g/kg, sparking fierce debate.
